Evidence map›Paper›PMID 35195738›Full record

Trial reportInternational urogynecology journal2022

The efficacy and safety of a single maintenance laser treatment for stress urinary incontinence: a double-blinded randomized controlled trial.

Roy Lauterbach, Saar Aharoni, Naphtali Justman, Naama Farago, Ilan Gruenwald, Lior Lowenstein

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in International urogynecology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 6 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 6 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Vaginal lasers for treating stress urinary incontinence in women.The Cochrane database of systematic reviews · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Fractional COInternational urogynecology journal · 2023
    Trial
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. COTherapeutic advances in urology
    Review
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Roy LauterbachDepartment of Obstetrics and Gynecology, Rambam Health Care Campus, 3109601, Haifa, Israel. r_lauterbach@rambam.health.gov.il.ORCID 0000-0002-1598-3586
Saar AharoniDepartment of Obstetrics and Gynecology, Rambam Health Care Campus, 3109601, Haifa, Israel.
Naphtali JustmanDepartment of Obstetrics and Gynecology, Rambam Health Care Campus, 3109601, Haifa, Israel.
Naama FaragoDepartment of Obstetrics and Gynecology, Rambam Health Care Campus, 3109601, Haifa, Israel.
Ilan GruenwaldDepartment of Obstetrics and Gynecology, Rambam Health Care Campus, 3109601, Haifa, Israel.
Lior LowensteinDepartment of Obstetrics and Gynecology, Galilee Medical Center, Nahariya, Israel.
Rambam Health Care Campus · ILBar-Ilan University · ILTechnion – Israel Institute of Technology · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and hypothesisTo evaluate the efficacy and safety of a single carbon dioxide (CO

methodsWomen aged 40-70 years who experienced temporary significant improvement in symptoms following CO

resultsOf 183 women screened, 131 were included in the final analysis. Demographic characteristics and baseline measures in the outcome tests were similar between the groups. Statistically significant improvements were demonstrated in the study compared to the control group at 3 months post-treatment in positive cough test (44.4% vs. 79.4%, P = 0.002), mean pad weight test (2.3 g ± 1.3 vs. 5.6 ± 1.1, P < 0.001), mean UDI-6(24.7 ± 12.1 vs. 45.1 ± 13.6 SD, P = 0.004), mean ICIQ-UI (16.5 ± 4.3 vs. 10.3 + 3.8, P = 0.003) and mean PISQ-12 (21.3 ± 6.8 vs. 36.6 ± 7.5, P = 0.003). However, values at 6 months post-treatment were similar to those at baseline.

conclusionsOur results suggest that a single maintenance laser treatment for reducing symptoms of SUI is transiently effective, well tolerated and safe. This treatment modality provides alternative non-surgical therapy for women with SUI.

Indexed as

Lasers, GasUrinary IncontinenceUrinary Incontinence, StressCarbon DioxideCoughFemaleHumansQuality of LifeSurveys and QuestionnairesTreatment OutcomeCarbon DioxideCarbon dioxide laserEfficacyLaser treatmentMaintenanceSafetyStress urinary incontinence

Identifiers

PMID35195738
PMCPMC8864590
OpenAlexW4212949805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.